床旁超声诊断肌少症对老年康复结局的影响:前瞻性队列研究
该前瞻性队列研究纳入215例70岁以上老年康复住院患者,基于握力和肌肉量(超声股直肌厚度、横截面积或生物电阻抗)并分别采用EWGSOP2或SDOC切点定义肌少症,评估其对非家庭出院、功能及移动障碍的预测能力。结果显示不同定义下肌少症患病率19.1%–34.4%,所有定义均能预测非家庭出院,股直肌厚度(EWGSOP2)预测非家庭出院AUC最高为0.68。
要点
- 床旁超声股直肌厚度预测非家庭出院AUC为0.68(95%CI 0.60-0.75)。
- 股直肌厚度和横截面积预测功能受损AUC分别为0.65和0.66。
- 仅股直肌横截面积(SDOC)预测移动障碍,AUC为0.61。
核心结论
- 基于床旁超声股直肌的肌少症诊断有助于预测老年康复结局,但预测能力因结局和切点而异。
- 需就床旁超声诊断肌少症的性别特异性握力和肌肉量切点达成共识。
研究设计与样本
- 前瞻性队列研究,纳入2023年瑞士伯尔尼一家三级老年康复医院215例70岁及以上住院患者。
主要发现
- 平均年龄84.0岁(SD 6.1),女性占64.2%。
- 不同肌少症定义下患病率为19.1%至34.4%。
- 49例(22.8%)非家庭出院,53例(24.7%)功能受损,96例(49.7%)移动障碍。
- 所有6种肌少症定义均能预测非家庭出院,股直肌厚度(EWGSOP2)AUC最高为0.68(95%CI 0.60-0.75)。
- 股直肌厚度和横截面积预测功能受损AUC分别为0.65(95%CI 0.58-0.72)和0.66(95%CI 0.57-0.73);仅股直肌横截面积(SDOC)预测移动障碍AUC为0.61(95%CI 0.54-0.68)。
关键数值与推荐
- 肌少症定义基于低握力和低肌肉量(EWGSOP2),肌肉量分别用超声股直肌厚度、超声股直肌横截面积和生物电阻抗评估。
- 另三种定义采用SDOC切点替代上述三种肌肉量评估的切点。
临床怎么用
- 对老年康复住院患者可考虑使用床旁超声测量股直肌厚度或横截面积辅助肌少症诊断和康复结局预测。
- 解读预测结果时需注意所用切点(EWGSOP2或SDOC)和结局类型不同,预测能力存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the predictive value of sarcopenia based on point-of-care ultrasound (POCUS) for geriatric rehabilitation outcomes among older patients. DESIGN: Prospective cohort study. SETTING AND PARTICIPANTS: A total of 215 inpatients aged 70+ years, admitted to a tertiary geriatric rehabilitation hospital in Bern, Switzerland, in 2023. METHODS: Sarcopenia was defined based on low grip strength and low muscle mass (European Working Group on Sarcopenia in Older People, EWGSOP2) applying definitions: (1) ultrasound rectus femoris thickness, (2) ultrasound rectus femoris cross-sectional area (CSA), and (3) bioelectrical impedance analysis (BIA). Sarcopenia definitions (4), (5), and (6) applied cutoffs of the Sarcopenia Definitions and Outcomes Consortium (SDOC) instead to each of the 3 preceding definitions. Predictive ability of these 6 sarcopenia definitions was assessed for nonhome discharge, functional and mobility impairment on discharge using area under the curve (AUC). RESULTS: Mean age was 84.0 (SD 6.1) years and 64.2% were women. Prevalence of sarcopenia ranged between 19.1% and 34.4% depending on the sarcopenia definition applied. Overall, 49 patients (22.8%) had nonhome discharge, 53 (24.7%) had functional impairment, and 96 (49.7%) had mobility impairment on discharge. Sarcopenia using all 6 definitions was predictive for nonhome discharge, with the highest AUC for the rectus femoris thickness (EWGSOP2) (AUC, 0.68; 95% CI, 0.60-0.75). Functional impairment was best predicted by rectus femoris thickness and CSA (AUC, 0.65; 95% CI, 0.58-0.72; AUC, 0.66; 95% CI, 0.57-0.73). Rectus femoris CSA (SDOC) was the only sarcopenia definition predicting impaired mobility (AUC, 0.61; 95% CI, 0.54-0.68). CONCLUSIONS AND IMPLICATIONS: Sarcopenia based on POCUS of the rectus femoris may contribute to prediction of rehabilitation outcomes. The predictive ability varied depending on the outcome and the cutoffs applied to diagnose sarcopenia implicating that it is key to reach agreement on the most valid sex-specific cutoffs for grip strength and muscle mass using POCUS to diagnose sarcopenia.
引用
- Merz N, Plessmann R, Netzer S, et al. Impact of Sarcopenia Diagnosed by Point-of-Care Ultrasound on Geriatric Rehabilitation Outcomes: A Prospective Cohort Study. J Am Med Dir Assoc. 2025. PMID: 40947099. doi:10.1016/j.jamda.2025.105873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。